文献速递炎症性肠病

炎症性肠病对急性冠脉综合征风险的影响:一项瑞典全国性队列研究

Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study.
PubMed 文献 · Aliment Pharmacol Ther · 2024-02-29

该瑞典全国性队列研究纳入2003-2021年确诊的76,517例炎症性肠病(IBD)患者,按出生年份、性别、日历年及居住地区与普通人群对照匹配。中位随访8年,IBD患者急性冠脉综合征(ACS)发病率为37.5/10,000人年,对照组为28.0/10,000人年(校正后HR 1.30;95%CI 1.24-1.35)。结论认为在现代IBD诊疗背景下,IBD患者ACS风险高于普通人群。

要点

  • IBD患者ACS风险高于普通人群,校正后HR为1.30(95%CI 1.24-1.35)。
  • 每100例IBD患者随访10年约额外发生1例ACS。
  • 风险升高主要见于老年起病(≥60岁)及伴肠外表现的CD或UC患者。

核心结论

  • 在现代IBD诊疗背景下,IBD患者发生ACS的风险高于普通人群。

研究设计与样本

  • 研究为队列研究,利用瑞典全国登记数据识别2003-2021年确诊的IBD患者。
  • 每例患者按出生年份、性别、日历年及居住地区与最多10名普通人群对照匹配。
  • 共纳入76,517例IBD患者(克罗恩病22,732例、溃疡性结肠炎42,194例、IBD未分型11,591例)和757,141例对照。
  • 主要结局为 incident ACS,采用半参数Cox比例风险模型估计HR。

主要发现

  • 中位随访8年,IBD患者中2,546例发生ACS(37.5/10,000人年),对照组19,598例(28.0/10,000人年)。
  • 校正混杂因素后,IBD患者ACS的HR为1.30(95%CI 1.24-1.35)。
  • 每100例IBD患者随访10年约额外发生1例ACS。
  • 老年起病IBD(≥60岁)及伴肠外表现的CD或UC患者HR最高。
  • 40岁前确诊IBD的患者未见HR升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are conflicting data on the risk of acute coronary syndrome (ACS) in patients with inflammatory bowel disease (IBD). Only a few previous reports include patients diagnosed during the last decade. AIM: To assess and compare the risk of ACS between patients with IBD and the general population. METHODS: In this cohort study, we used nationwide registers to identify patients diagnosed with IBD in Sweden 2003-2021. Every patient was matched by birth year, sex, calendar year and area of residence with up to 10 general population comparators. The primary outcome was incident ACS. We used semi-parametric Cox proportional hazard models to estimate hazard ratios (HRs). RESULTS: We identified 76,517 patients with IBD (Crohn's disease [CD], N = 22,732; ulcerative colitis [UC], N = 42,194 and IBD-unclassified, N = 11,591) and 757,141 comparators. During a median follow-up of 8 years, 2546 patients with IBD (37.5/10,000 person-years) were diagnosed with ACS compared with 19,598 (28.0/10,000 person-years) among comparators (HR 1.30; 95% confidence interval 1.24-1.35) after adjustments for confounding factors, and approximately one extra case of ACS in 100 IBD patients followed for 10 years. The highest HRs for ACS were in patients with elderly onset IBD (≥60 years) and among patients with CD or UC with extra-intestinal manifestations. No increased HRs were observed in patients diagnosed with IBD before the age of 40. CONCLUSION: In this contemporary cohort of patients with IBD, exposed to modern IBD care, there was an increased risk for ACS compared with individuals from the general population.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Eriksson C, Sun J, Bryder M, et al. Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study. Aliment Pharmacol Ther. 2024. PMID: 38425022. doi:10.1111/apt.17932

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。